Cardiol Therapeutics Inc. (TSX: CRDL)
Canada
· Delayed Price · Currency is CAD 1.870
-0.020 (-1.06%)
Dec 20, 2024, 4:00 PM EST
Cardiol Therapeutics Employees
Cardiol Therapeutics had 6 employees as of December 31, 2018.
Employees
6
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
152.60M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2018 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch + Lomb Corporation | 13,300 |
| Bausch Health Companies Inc. | 20,270 |
| WELL Health Technologies Corp. | 1,507 |
| dentalcorp Holdings Ltd. | 9,900 |
| Curaleaf Holdings, Inc. | 5,650 |
| Tilray Brands, Inc. | 2,650 |
| Sienna Senior Living Inc. | 12,263 |
| Cronos Group Inc. | 356 |
Cardiol Therapeutics News
- 3 days ago - PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis - GlobeNewsWire
- 4 weeks ago - CBD-Based Drug Reduces Pericarditis Pain And Inflammation, Shows New Clinical Study - Benzinga
- 4 weeks ago - Cardiol Therapeutics' Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024 - Newsfile Corp
- 5 weeks ago - Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index - GlobeNewsWire
- 2 months ago - IRW-News: Cardiol Therapeutics Inc. : Cardiol Therapeutics will CardiolRx in eine Studie der späten Phase an Patienten mit rezidivierender Perikarditis überführen - Onvista
- 2 months ago - Cardiol Therapeutics to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis - Newsfile Corp
- 2 months ago - Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option - Newsfile Corp
- 2 months ago - Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares - Newsfile Corp